SecBot SecBot
144 ·Filed Jun 15, 2026

XNCR

Xencor Inc
NEUTRAL
Impact 2/10
Horizonimmediate Processed5mo ago SEC0001959173-26-004639
Form 144, notice of proposed sale of securities
Actionable Insight • Neutral

This is a routine tax-motivated sale by a director with no discretionary signal. No trading action warranted; monitor for any unexpected insider selling patterns in future filings.

DirectionNeutral
Confidencehigh
Horizonimmediate

How the stock moved after the report

⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$12.21
T+0 close · Jun 15, 2026 · via day close
Latest settled
+104.26%
T+60 · $24.94
Vs SPY
+103.26%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Jun 15 $12.21entry
  2. T+1 · 5mo ago −0.08%α +0.51% · $12.20
  3. T+5 · 5mo ago +14.74%α +16.13% · $14.01
  4. T+20 · 4mo ago +22.52%α +23.27% · $14.96
  5. T+60 · 2mo ago +104.26%α +103.26% · $24.94
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Director Alan Bruce Montgomery filed a Form 144 notice of intent to sell 5,064 shares of Xencor Inc (XNCR) with an estimated market value of $62,337.84. The sale is a routine tax-withholding transaction tied to restricted stock vesting on June 12, 2026, and represents a negligible fraction of the company's $914M market cap.

Key Facts

  • Director Alan Bruce Montgomery filed Form 144 to sell 5,064 shares of XNCR common stock.
  • Estimated sale value is $62,337.84 (approx. $12.31/share).
  • Shares were acquired on June 12, 2026 via restricted stock vesting; sale is for tax withholding obligations.
  • Sale represents ~0.007% of XNCR's $914M market cap, immaterial.

Financial Impact

Negligible, $62k sale, less than 0.01% of market cap.

dilution

Risk Factors

  • None from this filing; the sale is non-discretionary and small.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
85% bullish (20 analysts)

Investment Themes

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
144 Filing (Primary)0001959173-26-004639
Document: 0001959173-26-004639-index.html0001959173-26-004639
Document: 0001959173-26-004639.txt0001959173-26-004639

Track record

20 reports on XNCR

Performance horizon

4 of 7 bullish or bearish reports moved the stock their way by T+1. Best: +67.24% at T+60 after the May 5, 2026 report. 5 of 7 went positive at some point.

Filters
  1. Nov 16, 2026today SC 13G/A Neutral 3/10 Entry $35.40 Now $35.40 +0.00% settles Nov 18
  2. Nov 13, 20263d ago SC 13G Neutral 3/10 Entry $39.23 Now $35.40 −9.77% settles Nov 17
  3. Nov 12, 20264d ago Insider Cluster Neutral 4/10 Entry $37.09 to $35.40 Now $35.40 −4.56% ▼ −4.56% −2.65% vs SPY
  4. Nov 12, 20264d ago 144 Neutral 2/10 Entry $38.13 to $37.09 Now $35.40 −7.16% ▼ −2.73% −2.36% vs SPY
  5. Nov 10, 20266d ago 144 Neutral 3/10 Entry $39.97 to $38.13 Now $35.40 −11.43% ▼ −4.60% −4.25% vs SPY
  6. Nov 6, 202610d ago SC 13G/A Neutral 3/10 Entry $35.75 to $38.59 Now $35.40 −0.98% ▲ +7.94% +5.58% vs SPY
  7. Nov 4, 202612d ago 8-K Neutral 5/10 Entry $34.05 to $35.75 Now $35.40 +3.96% ▲ +4.99% +4.68% vs SPY
  8. Oct 30, 202617d ago SC 13G/A Bearish 4/10 Entry $29.82 to $29.66 Now $35.40 −18.71% ▲ +0.54% +0.06% vs SPY
  9. Oct 27, 202620d ago SC 13G/A Neutral 2/10 Entry $29.99 to $29.21 Now $35.40 +18.04% ▼ −2.60% −2.22% vs SPY
  10. Oct 26, 202621d ago 8-K Bullish 6/10 Entry $29.18 to $29.99 Now $35.40 +21.32% ▲ +2.78% +2.22% vs SPY
Showing 10 of 20

US Market Status

Market Closed · Opens in 6h 34m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jun 15, 2026